Biotech

All Articles

CAMP 4 is actually most up-to-date to eye IPO, while Upstream define $182M plan

.RNA biotech CAMP4 Therapeutics has marked out prepare for a $67 thousand IPO, with inflammation-foc...

Galecto gets leukemia medication, goes down bone cancer cells asset in pivot

.A year after the breakdown of an idiopathic lung fibrosis applicant sent Galecto on a look for salv...

Judo throws down $100M to knock senseless kidney health condition

.Taking the floor covering is Judo Biography, an ambitious biotech equipped along with $100 million ...

AstraZeneca pays CSPC $100M for preclinical heart problem medication

.AstraZeneca has paid off CSPC Drug Team $one hundred million for a preclinical cardiovascular disea...

Zephyrm finds Hong Kong IPO to cash phase 3 cell therapy tests

.Zephyrm Bioscience is gusting towards the Hong Kong stock market, filing (PDF) for an IPO to stake ...

Frazier Lifestyle Sciences gets $630M for little, mid-cap biotechs

.Frazier Life Sciences has actually sourced a further $630 thousand for its fund paid attention to l...

GigaGen amasses as much as $135M BARDA money to beat botulism

.Antibody fan GigaGen, a subsidiary of Spanish biopharma Grifols, is ramping up its specialist to de...

GPCR agency Septerna declare IPO on durability of preclinical data

.Septerna is about to figure out how a biotech without "any sort of purposeful scientific informatio...

Kurma closes initially $154M loot for largest biotech fund as yet

.International VC agency Kurma Allies has actually unveiled its own most current biotech fund, along...

Prothena ensures one officer while one more places-- Chutes &amp Ladders

.Invite to today's Chutes &amp Ladders, our summary of considerable management hirings, shootings as...